EP Patent

EP0371431A2 — Supported drugs with increased dissolution rate, and a process for their preparation

Assigned to Adare Pharmaceuticals SRL · Expires 1990-06-06 · 36y expired

What this patent protects

Supported drugs with an increased dissolution rate, prepared by a process comprising mixing the drug with the support material under dry conditions, co-grinding the mixture in a mill with its grinding chamber saturated with the vapour of one or more solvents able to solubilize th…

USPTO Abstract

Supported drugs with an increased dissolution rate, prepared by a process comprising mixing the drug with the support material under dry conditions, co-grinding the mixture in a mill with its grinding chamber saturated with the vapour of one or more solvents able to solubilize the drug or to be adsorbed on the surface of the support material, vacuum-drying the product obtained, and sieving. The drugs obtained in this manner have a reduced heat of fusion, a reduced melting point, an increased dissolution rate and an increased solubilization kinetics.

Drugs covered by this patent

Patent Metadata

Patent number
EP0371431A2
Jurisdiction
EP
Classification
—
Expires
1990-06-06
Drug substance claim
No
Drug product claim
No
Assignee
Adare Pharmaceuticals SRL
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.